OUR PARTNERS
![img](https://media.jameelhealth.com/wp-content/uploads/2022/06/01085957/EYE-TECH-CARE-reversed-logo-300x112-ar.png)
OUR PARTNERS
Eye Tech Care, based in Lyon, France, was founded in 2008 by experts in the field of therapeutic ultrasound, in partnership with INSERM (National Institute of Health and Medical Research). It develops and markets medical devices for the non-invasive treatment of eye diseases.
Ultrasound is widely used in ophthalmology, including diagnostics (ultrasound biomicroscopy – ‘UBM’) for the imaging of the anterior chamber of the eye, and treatment (phacoemulsification procedure for cataracts as an example).
Focused ultrasound has already been used in many medical fields such as in the treatment of certain tumors and some neurological diseases.
When used at high frequency, focused ultrasound has the potential to coagulate tissues with pinpoint accuracy.
Eye Tech Care has developed a miniaturized device adapted to anatomy of the human eye, using focused ultrasound to coagulate portions of the ciliary body, to reduce the production of aqueous humor, thereby reducing intraocular pressure.
This is a simple, non-invasive, technique. The ultrasound beam easily passes through surface tissues, without damage, targeting the deep tissues without the need for surgery. The patented technology allows high precision of the focal zone, and control of the temperature rise at the focal point.
Visit: Eye Tech Care
Anyone who’s experienced healthcare will know it frequently falls short of this ideal. Why? It’s not a matter of lacking the necessary technology or methodologies; these tools are readily …
Globally, healthcare spending is growing faster than most economies. Is that because the more you spend, the better health outcomes you achieve? Unfortunately, not. Some countries seem to get …
Jameel Health is continually forging partnerships with leading organizations, researchers, innovators and thinkers in the global biotech and health industries. In 2021, it appointed Prof. James J. …
Healthcare – or rather adequate access to it – is one of the biggest challenges facing society today.
Despite the unprecedented levels of global wealth created by economic development over the past century, millions of people across vast regions of our planet are dying unnecessarily through poor …
The COVID-19 pandemic has been a stark reminder – if any were needed – of humankind’s persistent failure to address one of its most enduring, and potentially destabilizing, challenges – …
Health technology is transforming the way we can diagnose, treat and prevent disease, and has the potential to radically improve access to healthcare on a global scale.
From a longer-term historical perspective, the world we live in is undoubtedly fairer than it has ever been versus, say 100 years ago. In many – if not the majority – of countries across the …
Jameel Health has announced the creation of its new international commercial channel, helping to accelerate access to modern medical care and drive health inclusivity across the Global South.
Jameel Health appoints three globally respected scientists as special scientific advisors to join its mission in accelerating access to modern medical care across the global south.
©️ 2020-2024, Meddist Company Limited (Jameel Health). All rights in this Site are fully reserved. Permission to use this site is granted strictly subject to the Terms of Use. The Abdul Latif Jameel name, Jameel Health name; the Abdul Latif Jameel and Jameel Health logotypes and pentagon-shaped graphic are trademarks, or registered trademarks of Abdul Latif Jameel IPR Company Limited.
For medical incidence reporting please email: safety@jameelhealth.com or call +971 4 448 0905